ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
68,100
+5,500 (8.79%)
At close: Feb 27, 2026
303.91%
Market Cap 1.06T
Revenue (ttm) 20.33B
Net Income (ttm) -7.33B
Shares Out 15.62M
EPS (ttm) -669.94
PE Ratio n/a
Forward PE 124.73
Dividend n/a
Ex-Dividend Date n/a
Volume 912,857
Average Volume 420,120
Open 67,300
Previous Close 62,600
Day's Range 64,600 - 73,200
52-Week Range 13,740 - 87,000
Beta n/a
RSI 56.45
Earnings Date Mar 27, 2026

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.